Pre-order Enquiry
Request Free Sample
Global Recombinant Plasma Protein Therapeutics Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14003480 | Publishing Date : 20-Mar-2019 | No. of pages : 95
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Recombinant Plasma Protein Therapeutics Market Size, Status and Forecast 2019-2025
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chinese Hamster Ovary (CHO) Cell Line
1.4.3 Baby Hamster Kidney (BHK) Cell Line
1.4.4 Human Embryonic Kidney (HEK) Cell Line
1.4.5 Others
1.5 Market by Application
1.5.1 Global Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2025)
1.5.2 Hemophilia A
1.5.3 Hemophilia B
1.5.4 Von Willebrand Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Recombinant Plasma Protein Therapeutics Market Size
2.2 Recombinant Plasma Protein Therapeutics Growth Trends by Regions
2.2.1 Recombinant Plasma Protein Therapeutics Market Size by Regions (2014-2025)
2.2.2 Recombinant Plasma Protein Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Recombinant Plasma Protein Therapeutics Market Size by Manufacturers
3.1.1 Global Recombinant Plasma Protein Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Recombinant Plasma Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Recombinant Plasma Protein Therapeutics Key Players Head office and Area Served
3.3 Key Players Recombinant Plasma Protein Therapeutics Product/Solution/Service
3.4 Date of Enter into Recombinant Plasma Protein Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019)
4.2 Global Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
5.2 Recombinant Plasma Protein Therapeutics Key Players in United States
5.3 United States Recombinant Plasma Protein Therapeutics Market Size by Type
5.4 United States Recombinant Plasma Protein Therapeutics Market Size by Application
6 Europe
6.1 Europe Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
6.2 Recombinant Plasma Protein Therapeutics Key Players in Europe
6.3 Europe Recombinant Plasma Protein Therapeutics Market Size by Type
6.4 Europe Recombinant Plasma Protein Therapeutics Market Size by Application
7 China
7.1 China Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
7.2 Recombinant Plasma Protein Therapeutics Key Players in China
7.3 China Recombinant Plasma Protein Therapeutics Market Size by Type
7.4 China Recombinant Plasma Protein Therapeutics Market Size by Application
8 Japan
8.1 Japan Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
8.2 Recombinant Plasma Protein Therapeutics Key Players in Japan
8.3 Japan Recombinant Plasma Protein Therapeutics Market Size by Type
8.4 Japan Recombinant Plasma Protein Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
9.2 Recombinant Plasma Protein Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Type
9.4 Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Application
10 India
10.1 India Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
10.2 Recombinant Plasma Protein Therapeutics Key Players in India
10.3 India Recombinant Plasma Protein Therapeutics Market Size by Type
10.4 India Recombinant Plasma Protein Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Recombinant Plasma Protein Therapeutics Market Size (2014-2019)
11.2 Recombinant Plasma Protein Therapeutics Key Players in Central & South America
11.3 Central & South America Recombinant Plasma Protein Therapeutics Market Size by Type
11.4 Central & South America Recombinant Plasma Protein Therapeutics Market Size by Application
12 International Players Profiles
12.1 CSL Limited
12.1.1 CSL Limited Company Details
12.1.2 Company Description and Business Overview
12.1.3 Recombinant Plasma Protein Therapeutics Introduction
12.1.4 CSL Limited Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.1.5 CSL Limited Recent Development
12.2 Shire (Takeda Pharmaceutical Company Limited)
12.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Recombinant Plasma Protein Therapeutics Introduction
12.2.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.2.5 Shire (Takeda Pharmaceutical Company Limited) Recent Development
12.3 Octapharma
12.3.1 Octapharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Recombinant Plasma Protein Therapeutics Introduction
12.3.4 Octapharma Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.3.5 Octapharma Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Company Details
12.4.2 Company Description and Business Overview
12.4.3 Recombinant Plasma Protein Therapeutics Introduction
12.4.4 Novo Nordisk Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.4.5 Novo Nordisk Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Recombinant Plasma Protein Therapeutics Introduction
12.5.4 Bayer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Bioverativ Therapeutics, Inc. (Sanofi)
12.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Recombinant Plasma Protein Therapeutics Introduction
12.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
12.7 Aptevo Therapeutics
12.7.1 Aptevo Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Recombinant Plasma Protein Therapeutics Introduction
12.7.4 Aptevo Therapeutics Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.7.5 Aptevo Therapeutics Recent Development
12.8 Pharming Group
12.8.1 Pharming Group Company Details
12.8.2 Company Description and Business Overview
12.8.3 Recombinant Plasma Protein Therapeutics Introduction
12.8.4 Pharming Group Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.8.5 Pharming Group Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Recombinant Plasma Protein Therapeutics Introduction
12.9.4 Pfizer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)
12.9.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Recombinant Plasma Protein Therapeutics Market Size, Status and Forecast 2019-2025
List of Tables and FiguresTable Recombinant Plasma Protein Therapeutics Key Market Segments
Table Key Players Recombinant Plasma Protein Therapeutics Covered
Table Global Recombinant Plasma Protein Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type 2014-2025
Figure Chinese Hamster Ovary (CHO) Cell Line Figures
Table Key Players of Chinese Hamster Ovary (CHO) Cell Line
Figure Baby Hamster Kidney (BHK) Cell Line Figures
Table Key Players of Baby Hamster Kidney (BHK) Cell Line
Figure Human Embryonic Kidney (HEK) Cell Line Figures
Table Key Players of Human Embryonic Kidney (HEK) Cell Line
Figure Others Figures
Table Key Players of Others
Table Global Recombinant Plasma Protein Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hemophilia A Case Studies
Figure Hemophilia B Case Studies
Figure Von Willebrand Disease Case Studies
Figure Others Case Studies
Figure Recombinant Plasma Protein Therapeutics Report Years Considered
Table Global Recombinant Plasma Protein Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Recombinant Plasma Protein Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2014-2019
Figure Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2014-2019
Figure Global Recombinant Plasma Protein Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Recombinant Plasma Protein Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Share by Manufacturers in 2018
Table Global Recombinant Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Recombinant Plasma Protein Therapeutics Product/Solution/Service
Table Date of Enter into Recombinant Plasma Protein Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Size Share by Type (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Recombinant Plasma Protein Therapeutics Market Size Share by Application (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Recombinant Plasma Protein Therapeutics Revenue Market Share by Application in 2018
Figure United States Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table United States Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table United States Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table Europe Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table Europe Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure China Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table China Recombinant Plasma Protein Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table China Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure Japan Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table Japan Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table Japan Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure India Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table India Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table India Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Recombinant Plasma Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Recombinant Plasma Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Recombinant Plasma Protein Therapeutics Market Share (2018-2019)
Table Central & South America Recombinant Plasma Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Recombinant Plasma Protein Therapeutics Market Share by Type (2014-2019)
Table Central & South America Recombinant Plasma Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Recombinant Plasma Protein Therapeutics Market Share by Application (2014-2019)
Table CSL Limited Company Details
Table CSL Limited Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019) (Million US$)
Figure CSL Limited Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table CSL Limited Recent Development
Table Shire (Takeda Pharmaceutical Company Limited) Company Details
Table Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Shire (Takeda Pharmaceutical Company Limited) Recent Development
Table Octapharma Company Details
Table Octapharma Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Octapharma Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Octapharma Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Novo Nordisk Recent Development
Table Bayer Company Details
Table Bayer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Bayer Recent Development
Table Bioverativ Therapeutics, Inc. (Sanofi) Company Details
Table Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Bioverativ Therapeutics, Inc. (Sanofi) Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Bioverativ Therapeutics, Inc. (Sanofi) Recent Development
Table Aptevo Therapeutics Company Details
Table Aptevo Therapeutics Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Aptevo Therapeutics Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Aptevo Therapeutics Recent Development
Table Pharming Group Company Details
Table Pharming Group Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Pharming Group Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Pharming Group Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Recombinant Plasma Protein Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Recombinant Plasma Protein Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Global Recombinant Plasma Protein Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Recombinant Plasma Protein Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Recombinant Plasma Protein Therapeutics Market Size Share by Regions in 2025
Figure United States Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Recombinant Plasma Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Recombinant Plasma Protein Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Recombinant Plasma Protein Therapeutics Market Size by Product (2019-2025)
Figure Global Recombinant Plasma Protein Therapeutics Market Size by Product in 2025
Table Global Recombinant Plasma Protein Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Recombinant Plasma Protein Therapeutics Market Size by Application (2019-2025)
Figure Global Recombinant Plasma Protein Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Keyplayers in Global Recombinant Plasma Protein Therapeutics Market Size, Status and Forecast 2019-2025
CSL LimitedShire (Takeda Pharmaceutical Company Limited)
Octapharma
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer
